{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:00:31Z","timestamp":1760043631891},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T00:00:00Z","timestamp":1380499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2013,11]]},"abstract":"Abstract<\/jats:title>Introduction and Aims<\/jats:title>The study investigates patients' pre\u2010treatment expectations of, and post\u2010treatment satisfaction with, supervised injectable opiate treatment delivered within UK's first such clinics within the R<\/jats:styled-content>andomised I<\/jats:styled-content>njectable O<\/jats:styled-content>piate T<\/jats:styled-content>reatment T<\/jats:styled-content>rial (RIOTT<\/jats:styled-content>) (ISRCT<\/jats:styled-content>N0133807).<\/jats:p><\/jats:sec>Design and Methods<\/jats:title>Data were collected from 127 chronic heroin addicts recruited to RIOTT<\/jats:styled-content> and randomised to receive supervised injectable (heroin or methadone) treatment or optimised oral maintenance treatment at supervised injectable maintenance clinics in L<\/jats:styled-content>ondon, D<\/jats:styled-content>arlington and B<\/jats:styled-content>righton.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 127 RIOTT<\/jats:styled-content> patients, 113 (89%) provided responses to structured enquiry about treatment expectations, and 94 (74%) subsequent responses about treatment satisfaction (at six months). Patients were hoping that injectable heroin treatment would: reduce substance misuse (81%); help achieve normality, routine and structure (16%); and increase education and work prospects (15%). At six months, an area of treatment satisfaction most commonly reported by all three trial groups was reduced substance misuse (supervised injectable heroin 59%, supervised injectable methadone 56%, optimised oral methadone 54%). Most found supervision acceptable, but some desired modifications were also identified.<\/jats:p><\/jats:sec>Discussion and Conclusions<\/jats:title>Patients previously considered non\u2010responsive to treatment appear to have similar treatment expectations and aspirations as other drug users in treatment. Supervised injectable opioid treatment patients consistently reported treatment satisfaction but also that more could be done to optimise aspects of current arrangement. This raised the challenging issue of the extent to which opinions of patients need to be taken into consideration in shaping future treatment provision. Future research may need to examine the extent of expectations \u2018fit\u2019 and the relationship between treatment sought and received. [Groshkova T, Metrebian N, Hallam C, Charles V, Martin A, Forzisi L, Lintzeris N, Strang J. Treatment expectations and satisfaction of treatment\u2010refractory opioid dependent patients in R<\/jats:styled-content>andomised I<\/jats:styled-content>njectable O<\/jats:styled-content>piate T<\/jats:styled-content>reatment T<\/jats:styled-content>rial, the UK's first supervised injectable maintenance clinics. <\/jats:italic>Drug Alcohol Rev 2013;32:566\u2013573]<\/jats:italic><\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.12062","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T01:38:17Z","timestamp":1381541897000},"page":"566-573","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment expectations and satisfaction of treatment\u2010refractory opioid\u2010dependent patients in RIOTT, the R<\/scp>andomised I<\/scp>njectable O<\/scp>piate T<\/scp>reatment T<\/scp>rial, the UK<\/scp>'s first supervised injectable maintenance clinics"],"prefix":"10.1111","volume":"32","author":[{"given":"Teodora","family":"Groshkova","sequence":"first","affiliation":[{"name":"National Addiction Centre King's College London London UK"},{"name":"European Monitoring Centre for Drugs and Drug Addiction Lisbon Portugal"}]},{"given":"Nicola","family":"Metrebian","sequence":"additional","affiliation":[{"name":"National Addiction Centre King's College London London UK"}]},{"given":"Christopher","family":"Hallam","sequence":"additional","affiliation":[{"name":"National Addiction Centre King's College London London UK"},{"name":"International Drug Policy Consortium London UK"}]},{"given":"Vikki","family":"Charles","sequence":"additional","affiliation":[{"name":"National Addiction Centre King's College London London UK"}]},{"given":"Anthea","family":"Martin","sequence":"additional","affiliation":[{"name":"National Addiction Centre King's College London London UK"}]},{"given":"Luciana","family":"Forzisi","sequence":"additional","affiliation":[{"name":"National Addiction Centre King's College London London UK"}]},{"given":"Nicholas","family":"Lintzeris","sequence":"additional","affiliation":[{"name":"National Addiction Centre King's College London London UK"},{"name":"Academic Health Sciences Centre King's Health Partners London UK"},{"name":"Langton Centre Sydney University Sydney Australia"}]},{"given":"John","family":"Strang","sequence":"additional","affiliation":[{"name":"National Addiction Centre King's College London London UK"},{"name":"Academic Health Sciences Centre King's Health Partners London UK"}]}],"member":"311","published-online":{"date-parts":[[2013,9,30]]},"reference":[{"key":"e_1_2_7_2_1","volume-title":"Health and Social Care Act","author":"Department of Health","year":"2008"},{"key":"e_1_2_7_3_1","unstructured":"National Treatment Agency (NTA) for Substance Misuse: NTA Guidance for Local Partnerships on User and Carer Involvement. London: NTA November2006: Available at:http:\/\/www.nta.nhs.uk\/Who\u2010service\u2010involved.aspx. (accessed March 2011)."},{"key":"e_1_2_7_4_1","volume-title":"Essence of Care: benchmarks for Promoting Health","author":"Department of Health","year":"2006"},{"key":"e_1_2_7_5_1","first-page":"188","volume-title":"Heroin in the age of crack\u2010cocaine, drugs, health, and social policy series","author":"Hunt G","year":"1998"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2524.1998.00140.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/09687639997313"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.3109\/09687630903357718"},{"key":"e_1_2_7_9_1","volume-title":"Heroin addiction and drug policy: the British system","author":"Strang J","year":"1994"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2003.00668.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00193.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2008.00015.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(10)70001-8"},{"key":"e_1_2_7_14_1","unstructured":"UK Government Drug Strategy.The Home Office 2010. Available at:http:\/\/www.homeoffice.gov.uk\/publications\/alcohol\u2010drugs\/drugs\/drug\u2010strategy\/drug\u2010strategy\u20102010(accessed March 2011)."},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60349-2"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-3-28"},{"key":"e_1_2_7_17_1","first-page":"142","article-title":"New heroin\u2010assisted treatment : recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond","volume":"11","author":"Strang J","year":"2012","journal-title":"EMCDDA Insights"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000141646"},{"key":"e_1_2_7_19_1","first-page":"23","article-title":"Recovery and me: a personal story from our new Members\u2032 Council recruit. South London & Maudsley NHS Foundation Trust","author":"Clark S. RIOTT","year":"2009","journal-title":"London. SLaM News"},{"key":"e_1_2_7_20_1","first-page":"27","article-title":"I predict a RIOTT","volume":"14","author":"Hannah X.","year":"2012","journal-title":"Black Poppy"},{"key":"e_1_2_7_21_1","volume-title":"NTA Full Guidance Report for Injectable heroin (and injectable methadone): potential roles in drug treatment","author":"National Treatment Agency","year":"2003"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdar.12062","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.12062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:04:18Z","timestamp":1696334658000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.12062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,30]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1111\/dar.12062"],"URL":"https:\/\/doi.org\/10.1111\/dar.12062","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,30]]},"assertion":[{"value":"2012-11-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-05-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-09-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}